RxDoctor Payments Data

Alexander Leos, DPM

Foot & Ankle Surgery · New Orleans, LANPI 1750900221

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (48.5%), education and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by ALON Medical Technology at 38.0% of the total. Reporting peaked in 2022 at $2,760 and has fallen 51.0% since, to $1,352 in 2025.

$7,964in general payments, 2019–2025

Across 89 payments — averaging $89.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ALON Medical Technology$3K
  • Stryker$2K
  • Arthrex$600
  • Averitas Pharma Inc.$549
  • Orthofix Medical, Inc.$499
  • Paragon 28, Inc.$173
  • plus $1K from 10 others

What the payments were for

  • Travel & lodging$1,69821%
  • Food & beverage$3,86549%
  • Education$2,40030%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,964 in reported general payments places this provider in the 70th percentile of 92 foot & ankle surgery providers in Louisiana.

See all foot & ankle surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$39,952
Medicare patients
189
Services billed
1,085

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Duloxetine Hcl377$4,423
Terbinafine Hcl127$2,757
Ammonium Lactate93$2,593
Ketoconazole103$2,438
Amitriptyline Hcl277$2,362
Ciclopirox101$2,021
Gabapentin175$1,758
Dexamethasone207$1,606
Pregabalin177$1,528
Itraconazole11$1,155
Levofloxacin24$1,151
Fluorouracil25$1,147
Imiquimod26$583
Doxycycline Hyclate75$560
Oxycodone Hcl89$528

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →